ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Frazier Life Sciences Viii, L.P. bought $8.5M of Arcutis Biotherapeutics, Inc.
10% owner
Bought$8,500,000
$17.00Price
500,000Shares
+5%Stake
What ARQT did for a copier
Prices for ARQT after this filing aren't in yet.
Frazier Life Sciences Viii, L.P.'s record
2 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Feb 4. Filed Thu, Feb 6, 5:29 AM ET, before the open. Not investment advice.